Management of viral hepatitis in liver transplant recipients.

Recurrence of viral hepatitis after liver transplantation (LT) can progress to graft failure and lead to a decrease in long-term survival. Recently, there have been remarkable improvement in the treatment of chronic hepatitis B (CHB) using potent antiviral agents. Combination of hepatitis B immunoglobulin and potent antiviral therapy has brought marked advances in the management of CHB for liver transplant recipients. Post-transplant antiviral therapy for hepatitis C virus infection is generally reserved for patients showing progressive disease. Acheiving a sustained virological response in patients with LT greatly ameliorates graft and overall survival, however this only occurs in 30% of transplant recipient using pegylated interferon and ribavirin (RBV). Direct acting antivirals such as protease inhibitors, polymerase or other non-structural proteins inhibitors are anticipated to establish the new standard of care for transplant recipients. In liver transplant recipients, hepatitis E virus infection is an uncommon disease. However, it can lead to chronic hepatitis and cirrhosis and may require retransplantation. Recently, 3-month course of RBV monotherapy has been reported as an effective treatment. This review focuses on the recent management and therapeutic approaches of viral hepatitis in liver transplant recipient.
AuthorsSoung Won Jeong, YoungRok Choi, Jin-Wook Kim
JournalClinical and molecular hepatology (Clin Mol Hepatol) Vol. 20 Issue 4 Pg. 338-44 (Dec 2014) ISSN: 2287-285X [Electronic] Korea (South)
PMID25548738 (Publication Type: Journal Article, Review)
Chemical References
  • Antiviral Agents
  • Antiviral Agents (therapeutic use)
  • Hepatitis B (drug therapy, pathology, surgery)
  • Hepatitis C (drug therapy, pathology, surgery)
  • Hepatitis E (drug therapy, pathology, surgery)
  • Hepatitis, Viral, Human (drug therapy, pathology, surgery)
  • Humans
  • Liver Transplantation
  • Recurrence

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: